Gain Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Gain Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease (NCT07280299) | Gain Therapeutics, Inc. | 2026-05-30 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease (NCT06732180) | Gain Therapeutics, Inc. | 2025-02-21 |
Track Gain Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.